| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |